 | • レポートコード：20QY06-00136 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：食品・飲料 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、A型肝炎ワクチンのグローバル市場について種類別（不活化ワクチン、弱毒生ワクチン）、用途別（政府機関、民間部門、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・A型肝炎ワクチン市場の概要 ・世界の主要地域別A型肝炎ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のA型肝炎ワクチン市場規模2015-2026：種類別（不活化ワクチン、弱毒生ワクチン） ・世界のA型肝炎ワクチン市場規模2015-2026：用途別（政府機関、民間部門、その他） ・A型肝炎ワクチンの北米市場規模2015-2020 ・A型肝炎ワクチンのヨーロッパ市場規模2015-2020 ・A型肝炎ワクチンの中国市場規模2015-2020 ・A型肝炎ワクチンの日本市場規模2015-2020 ・A型肝炎ワクチンの東南アジア市場規模2015-2020 ・A型肝炎ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、Merck、Sanofi、Sinovac、Zhejiang Pukang、Changchun Institute of Biological、KM Biologics、IMBCA、ChangSheng、Convac） ・A型肝炎ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・A型肝炎ワクチンの市場動向・機会・課題 ・調査の結論 |
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Market Analysis and Insights: Global Hepatitis A Vaccine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hepatitis A Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hepatitis A Vaccine industry.
Based on our recent survey, we have several different scenarios about the Hepatitis A Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 677 million in 2019. The market size of Hepatitis A Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Hepatitis A Vaccine Scope and Market Size
The global Hepatitis A Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis A Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hepatitis A Vaccine market is segmented into
Inactivated Vaccine
Live Attenuated Vaccine
Segment by Application, the Hepatitis A Vaccine market is segmented into
Government Institution
Private Sector
Other
The Hepatitis A Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Hepatitis A Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hepatitis A Vaccine Market Share Analysis
Hepatitis A Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepatitis A Vaccine business, the date to enter into the Hepatitis A Vaccine market, Hepatitis A Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
1 Hepatitis A Vaccine Market Overview
1.1 Hepatitis A Vaccine Product Scope
1.2 Hepatitis A Vaccine Segment by Type
1.2.1 Global Hepatitis A Vaccine Sales by Type (2020-2026)
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Segment by Application
1.3.1 Global Hepatitis A Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Hepatitis A Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hepatitis A Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Hepatitis A Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Hepatitis A Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Hepatitis A Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Hepatitis A Vaccine Industry
1.5.1.1 Hepatitis A Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hepatitis A Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hepatitis A Vaccine Players to Combat Covid-19 Impact
2 Hepatitis A Vaccine Estimate and Forecast by Region
2.1 Global Hepatitis A Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hepatitis A Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Hepatitis A Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Hepatitis A Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hepatitis A Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hepatitis A Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hepatitis A Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Hepatitis A Vaccine Estimates and Projections (2015-2026)
2.4.3 China Hepatitis A Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Hepatitis A Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hepatitis A Vaccine Estimates and Projections (2015-2026)
2.4.6 India Hepatitis A Vaccine Estimates and Projections (2015-2026)
3 Global Hepatitis A Vaccine Competition Landscape by Players
3.1 Global Top Hepatitis A Vaccine Players by Sales (2015-2020)
3.2 Global Top Hepatitis A Vaccine Players by Revenue (2015-2020)
3.3 Global Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Vaccine as of 2019)
3.4 Global Hepatitis A Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Hepatitis A Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hepatitis A Vaccine Players (Opinion Leaders)
4 Global Hepatitis A Vaccine Market Size by Type
4.1 Global Hepatitis A Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Hepatitis A Vaccine Price by Type (2014-2020)
4.2 Global Hepatitis A Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hepatitis A Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Hepatitis A Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Hepatitis A Vaccine Price Forecast by Type (2021-2026)
5 Global Hepatitis A Vaccine Market Size by Application
5.1 Global Hepatitis A Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Hepatitis A Vaccine Price by Application (2015-2020)
5.2 Global Hepatitis A Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hepatitis A Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Hepatitis A Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepatitis A Vaccine Price Forecast by Application (2021-2026)
3 North America Hepatitis A Vaccine Market Facts & Figures
3.2 North America Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
4 Europe Hepatitis A Vaccine Market Facts & Figures
4.2 Europe Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
5 China Hepatitis A Vaccine Market Facts & Figures
5.2 China Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
5.3 China Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
5.4 China Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
6 Japan Hepatitis A Vaccine Market Facts & Figures
6.2 Japan Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Hepatitis A Vaccine Market Facts & Figures
7.2 Southeast Asia Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
8 India Hepatitis A Vaccine Market Facts & Figures
8.2 India Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
8.3 India Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
8.4 India Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hepatitis A Vaccine Business
12.1 GSK
12.1.1 GSK Hepatitis A Vaccine Corporation Information
12.1.2 GSK Hepatitis A Vaccine Business Overview and Total Revenue
12.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Hepatitis A Vaccine Products Offered
12.1.5 GSK Recent Development
12.2 Merck
12.2.1 Merck Hepatitis A Vaccine Corporation Information
12.2.2 Merck Hepatitis A Vaccine Business Overview and Total Revenue
12.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Hepatitis A Vaccine Products Offered
12.2.5 Merck Recent Development
12.3 Sanofi
12.3.1 Sanofi Hepatitis A Vaccine Corporation Information
12.3.2 Sanofi Hepatitis A Vaccine Business Overview and Total Revenue
12.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Hepatitis A Vaccine Products Offered
12.3.5 Sanofi Recent Development
12.4 Sinovac
12.4.1 Sinovac Hepatitis A Vaccine Corporation Information
12.4.2 Sinovac Hepatitis A Vaccine Business Overview and Total Revenue
12.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sinovac Hepatitis A Vaccine Products Offered
12.4.5 Sinovac Recent Development
12.5 Zhejiang Pukang
12.5.1 Zhejiang Pukang Hepatitis A Vaccine Corporation Information
12.5.2 Zhejiang Pukang Hepatitis A Vaccine Business Overview and Total Revenue
12.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Zhejiang Pukang Hepatitis A Vaccine Products Offered
12.5.5 Zhejiang Pukang Recent Development
12.6 Changchun Institute of Biological
12.6.1 Changchun Institute of Biological Hepatitis A Vaccine Corporation Information
12.6.2 Changchun Institute of Biological Hepatitis A Vaccine Business Overview and Total Revenue
12.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Changchun Institute of Biological Hepatitis A Vaccine Products Offered
12.6.5 Changchun Institute of Biological Recent Development
12.7 KM Biologics
12.7.1 KM Biologics Hepatitis A Vaccine Corporation Information
12.7.2 KM Biologics Hepatitis A Vaccine Business Overview and Total Revenue
12.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 KM Biologics Hepatitis A Vaccine Products Offered
12.7.5 KM Biologics Recent Development
12.8 IMBCA
12.8.1 IMBCA Hepatitis A Vaccine Corporation Information
12.8.2 IMBCA Hepatitis A Vaccine Business Overview and Total Revenue
12.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 IMBCA Hepatitis A Vaccine Products Offered
12.8.5 IMBCA Recent Development
12.9 ChangSheng
12.9.1 ChangSheng Hepatitis A Vaccine Corporation Information
12.9.2 ChangSheng Hepatitis A Vaccine Business Overview and Total Revenue
12.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 ChangSheng Hepatitis A Vaccine Products Offered
12.9.5 ChangSheng Recent Development
12.10 Convac
12.10.1 Convac Hepatitis A Vaccine Corporation Information
12.10.2 Convac Hepatitis A Vaccine Business Overview and Total Revenue
12.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Convac Hepatitis A Vaccine Products Offered
12.10.5 Convac Recent Development
13 Hepatitis A Vaccine Manufacturing Cost Analysis
13.1 Hepatitis A Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hepatitis A Vaccine
13.4 Hepatitis A Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hepatitis A Vaccine Distributors List
14.3 Hepatitis A Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hepatitis A Vaccine Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Hepatitis A Vaccine Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Hepatitis A Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Hepatitis A Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Hepatitis A Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Hepatitis A Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Hepatitis A Vaccine Sales (K MT) by Region (2015-2020)
Table 10. Global Hepatitis A Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Hepatitis A Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Hepatitis A Vaccine Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Hepatitis A Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Hepatitis A Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Hepatitis A Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Hepatitis A Vaccine (K MT) of Key Companies (2015-2020)
Table 18. Global Hepatitis A Vaccine Sales Share by Company (2015-2020)
Table 19. Global Hepatitis A Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Hepatitis A Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Hepatitis A Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis A Vaccine as of 2019)
Table 22. Global Hepatitis A Vaccine Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Hepatitis A Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Hepatitis A Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Hepatitis A Vaccine Players
Table 27. Global Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 28. Global Hepatitis A Vaccine Sales Share by Type (2015-2020)
Table 29. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Hepatitis A Vaccine Price (K MT) by Type (2015-2020)
Table 31. Global Hepatitis A Vaccine Sales Share by Type (2021-2026)
Table 32. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Hepatitis A Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Hepatitis A Vaccine Price (K MT) by Type (2021-2026)
Table 35. Global Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 36. Global Hepatitis A Vaccine Sales Share by Application (2015-2020)
Table 37. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Hepatitis A Vaccine Price (K MT) by Application (2015-2020)
Table 39. Global Hepatitis A Vaccine Sales (K MT) by Application (2021-2026)
Table 40. Global Hepatitis A Vaccine Sales Share by Application (2021-2026)
Table 41. Global Hepatitis A Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Hepatitis A Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Hepatitis A Vaccine Price (K MT) by Application (2021-2026)
Table 44. United States Hepatitis A Vaccine Sales (K MT) by Company (2015-2020)
Table 45. United States Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 47. United States Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 49. United States Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Hepatitis A Vaccine Sales (K MT) by Company (2015-2020)
Table 51. Europe Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 53. Europe Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 55. Europe Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Hepatitis A Vaccine Sales (K MT) by Company (2015-2020)
Table 57. China Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 59. China Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 61. China Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Hepatitis A Vaccine Sales (K MT) by Company (2015-2020)
Table 63. Japan Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 65. Japan Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 67. Japan Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Hepatitis A Vaccine Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Hepatitis A Vaccine Sales (K MT) by Company (2015-2020)
Table 75. India Hepatitis A Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Hepatitis A Vaccine Sales (K MT) by Type (2015-2020)
Table 77. India Hepatitis A Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Hepatitis A Vaccine Sales (K MT) by Application (2015-2020)
Table 79. India Hepatitis A Vaccine Sales Market Share by Application (2015-2020)
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GSK Hepatitis A Vaccine Product
Table 84. GSK Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Business Overview
Table 87. Merck Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Merck Hepatitis A Vaccine Product
Table 89. Merck Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sanofi Hepatitis A Vaccine Product
Table 94. Sanofi Recent Development
Table 95. Sinovac Corporation Information
Table 96. Sinovac Description and Business Overview
Table 97. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sinovac Hepatitis A Vaccine Product
Table 99. Sinovac Recent Development
Table 100. Zhejiang Pukang Corporation Information
Table 101. Zhejiang Pukang Description and Business Overview
Table 102. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Zhejiang Pukang Hepatitis A Vaccine Product
Table 104. Zhejiang Pukang Recent Development
Table 105. Changchun Institute of Biological Corporation Information
Table 106. Changchun Institute of Biological Description and Business Overview
Table 107. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Changchun Institute of Biological Hepatitis A Vaccine Product
Table 109. Changchun Institute of Biological Recent Development
Table 110. KM Biologics Corporation Information
Table 111. KM Biologics Description and Business Overview
Table 112. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. KM Biologics Hepatitis A Vaccine Product
Table 114. KM Biologics Recent Development
Table 115. IMBCA Corporation Information
Table 116. IMBCA Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. IMBCA Description and Business Overview
Table 118. IMBCA Hepatitis A Vaccine Product
Table 119. IMBCA Recent Development
Table 120. ChangSheng Corporation Information
Table 121. ChangSheng Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. ChangSheng Description and Business Overview
Table 123. ChangSheng Hepatitis A Vaccine Product
Table 124. ChangSheng Recent Development
Table . Convac Corporation Information
Table . Convac Description and Business Overview
Table . Convac Hepatitis A Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Convac Hepatitis A Vaccine Product
Table . Convac Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Hepatitis A Vaccine Distributors List
Table 133. Hepatitis A Vaccine Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis A Vaccine Product Picture
Figure 2. Global Hepatitis A Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hepatitis A Vaccine Market Share by Application in 2020 & 2026
Figure 6. Government Institution Examples
Figure 7. Private Sector Examples
Figure 8. Other Examples
Figure 9. Global Hepatitis A Vaccine Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Hepatitis A Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hepatitis A Vaccine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Hepatitis A Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hepatitis A Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hepatitis A Vaccine Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hepatitis A Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hepatitis A Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hepatitis A Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hepatitis A Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hepatitis A Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hepatitis A Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hepatitis A Vaccine Players Market Share by Revenue in Hepatitis A Vaccine 2015 & 2019
Figure 27. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hepatitis A Vaccine Revenue Share by Type (2015-2020)
Figure 29. Global Hepatitis A Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hepatitis A Vaccine Revenue Share by Application (2015-2020)
Figure 31. Global Hepatitis A Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 33. United States Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 34. Europe Hepatitis A Vaccine Sales Market Share by Company in 2019
Figure 35. Europe Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 36. Europe Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 37. China Hepatitis A Vaccine Sales Market Share by Company in 2019
Figure 38. China Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 39. China Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 40. Japan Hepatitis A Vaccine Sales Market Share by Company in 2019
Figure 41. Japan Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 42. Japan Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hepatitis A Vaccine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 46. India Hepatitis A Vaccine Sales Market Share by Company in 2019
Figure 47. India Hepatitis A Vaccine Sales Market Share by Type in 2019
Figure 48. India Hepatitis A Vaccine Sales Market Share by Application in 2019
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sinovac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Zhejiang Pukang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Changchun Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. KM Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. IMBCA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. ChangSheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Convac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Hepatitis A Vaccine
Figure 61. Manufacturing Process Analysis of Hepatitis A Vaccine
Figure 62. Hepatitis A Vaccine Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
全ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global All Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…- ライム病ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Lyme Disease Vaccine Market The global Lyme Disease Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Lyme Disease Vaccine Scope and Market Size The global Lyme …
- 多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …
- 食用ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Edible Vaccine Market The global Edible Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Edible Vaccine Scope and Market Size The global Edible Vaccine market i…
- ペット用ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Pet Vaccine Market The global Pet Vaccine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Pet Vaccine Scope and Market Size The global Pet Vaccine market is segmented …